Researchers assessed the ability of a machine learning model to predict the risk of 30-day mortality among patients with community-acquired pneumonia.
Researchers assessed temporal and regional trends to estimate the global rate of macrolide-resistant Mycoplasma pneumoniae infections.
Could thoracic HRCT semiquantitative scoring offer a rapid and accurate method for identifying patients with severe COVID-19 who are at risk for poor outcomes?
Researchers assessed variations in cortisol concentrations among children and adolescents with acute illnesses and no history of glucocorticoid deficiency.
Researchers compared the risk for pneumonia and sepsis in patients with type 2 diabetes on sodium-glucose contransporter-2 vs dipeptidyl peptidase-4 inhibitors.
A meta-analysis of children treated as outpatients for community-acquired pneumonia compared outcomes of short-course vs long-course antibiotic treatment.
Can patients at low-risk for COVID-19 pneumonia be identified upon hospital admission based on patient data and minor criteria developed by IDSA and ATS?
Researchers performed a network analysis to compare the efficacy of 3 treatments for community-acquired pneumonia.
Researchers assessed whether antibiotic treatment differed on the basis of pneumococcal urinary antigen test results among patients hospitalized with community-acquired pneumonia.
For children, Vaxneuvance is administered as a 4-dose series at 2, 4, 6 and 12 through 15 months of age (and at least 2 months after the 3rd dose).
Researchers assessed the association between dexamethasone treatment and the occurrence of superinfections among patients with severe COVID-19.
Researchers examined the relationship between multiple factors related to heart failure and worse outcomes in patients hospitalized for pneumonia.
Researchers assessed the influence of intrapartum antibiotic prophylaxis on the emergence of antimicrobial resistant Group B streptococcal isolates.
Researchers assessed the incidence of pneumocystis pneumonia among individuals in Germany between 2014 and 2019.
Researched compared the efficacy of erythromycin with clarithromycin for the treatment of community-acquired pneumonia.
Researchers assessed morbidity and mortality outcomes following surgical resection for nonsmall cell lung cancer among patients with and without prior COVID-19 pneumonia.
Researchers evaluated the effects of nasogastric tube feeding vs careful hand feeding on survival outcomes and the risk for pneumonia among older patients with advanced dementia.
Researchers assessed outcomes and risk factors associated with thromboembolic events among patients with COVID-19 pneumonia.
Is VTE risk unusually high in patients with COVID-19? To find out, researchers compared VTE incidence in inpatients with COVID-19 vs those with CAP.
How does the duration of respiratory distress in severe COVID-19 pneumonia affect the need for invasive mechanical ventilation, mortality, and length of hospital stay?